Bluetongue virus serotype 12 in the Netherlands in 2024 - A BTV serotype reported in Europe for the first time

Rene van den Brom,Inge Santman-Berends,Mark G. van der Heijden,Frank Harders,Marc Y. Engelsma,Rene van Gennip,Mieke Maris-Veldhuis,Arno-Jan Feddema,Karianne Petterson,Natalia Golender,Marcel Spierenburg,Piet Antonius van Rijn,Melle Holwerda

DOI: https://doi.org/10.1101/2024.12.03.626362

2024-12-06

Abstract:Bluetongue (BT) is a viral midge borne disease primarily affecting ruminants such as sheep, cattle, and goats. In 2023, the Netherlands reported the first case of bluetongue virus serotype 3 (BTV-3), after being BTV free for eleven years. Since May 2024, vaccination with inactivated BT vaccines for serotype 3 was applied in the Netherlands. Nonetheless, in late June/July 2024, BTV-3 re-emerged and spread over large parts of Europe. In October 2024, BTV-12 was identified by follow-up diagnostics after a BTV-3 vaccinated sheep with signs of BT was tested positive for BTV but negative for serotype 3. This marks a significant event, as BTV-12 had never been reported in Europe. Screening of farms in close proximity to the sheep farm and retrospective analysis of previously BTV PCR positive tested clinical suspicions, resulted in nine BTV-12 affected farms in total. The emergence of BTV-12 in the Netherlands raises important questions about the route of introduction of BT in the Netherlands and mechanisms of viral spread of this specific serotype. Possible adaptation of new BTV serotypes to the European climatic and husbandry conditions prompts reconsideration of surveillance, prevention, and control strategies in relation to changing ecological conditions and vector dynamics. The initial findings, respective studies as well as the initial attempts to trace the origin of BTV-12 are described.

Zoology

What problem does this paper attempt to address?

The problems that this paper attempts to solve are: **the origin, transmission routes of Bluetongue virus type 12 (BTV - 12) first discovered in the Netherlands, and its impact on the local livestock industry**. Specifically, the research mainly focuses on the following aspects:

1. **First discovery and confirmation**:
- On September 16, 2024, BTV - 12 was first detected in a flock of sheep in the Netherlands, which was the first report of this serotype in Europe. Although these sheep had been vaccinated against BTV - 3, they still showed symptoms of bluetongue disease.

2. **Subsequent investigation and traceability**:
- The paper describes the large - scale investigations that followed, including screening of nearby farms and retrospective analysis of previously PCR - positive samples. Through these measures, the researchers found a total of nine BTV - 12 - positive farms (seven dairy farms and two sheep farms).
- The researchers also carried out whole - genome sequencing and phylogenetic analysis to determine the genetic characteristics of BTV - 12/NET2024 and its possible geographical origin.

3. **Virus transmission mechanism**:
- The research explored the transmission mechanism of BTV - 12 in the Netherlands, especially whether it is transmitted by vector insects such as Culicoides spp. The results showed that most BTV - 12 cases were concentrated near the first two cases, while a few cases occurred in more distant areas, indicating that the virus spreads slowly or there are other transmission routes.

4. **Re - evaluation of prevention and control strategies**:
- The emergence of BTV - 12 has triggered thinking about future bluetongue disease prevention and control strategies. Is the current single - serotype vaccine sufficient to deal with the threat of multiple serotypes? Will climate change affect the activity patterns of vector insects, thereby increasing the risk of invasion of new serotypes?

### Formula representation

Although the content involved in this article is mainly biology and epidemiology, some mathematical formulas may be used when discussing virus transmission models. For example, the following formula can be used to calculate the confidence interval of the positive rate in a sample:

\[ \text{Confidence interval} = p \pm z \sqrt{\frac{p(1 - p)}{n}} \]

where:
- \( p \) is the positive rate in the sample,
- \( z \) is the critical value of the standard normal distribution corresponding to the required confidence level,
- \( n \) is the sample size.

### Summary

The core issue of the paper is to understand the first appearance of BTV - 12 in the Netherlands and its potential impacts, and to provide a scientific basis for future bluetongue disease prevention and control. Through detailed molecular biology and epidemiology research, the researchers hope to reveal the origin and transmission path of BTV - 12 and evaluate the effectiveness of existing prevention and control measures.